Javascript must be enabled to continue!
Treatment of Cherubism with Salmon Calcitonin: A Case Report
View through CrossRef
ABSTRACTCherubism is a familial disease of the jaws which is inherited via autosomal dominant manner. Typical features of cherubism include a painless bilateral, symmetrical enlargement of the jaws, misalignment of teeth, and intra-osseous central giant cell granuloma-like lesions, which are usually evident in early childhood. Treatment of cherubism consists of local curettage of the lesions, jaw contouring, intralesional steroid injections, and systemic calcitonin administration as well. Calcitonin therapy for central giant cell granuloma of the jaws is well documented, and favorable results have been achieved. However, fewer reports have been presented in regard to calcitonin administration for cherubism. In the present report, a 14-year-old boy with cherubism who had intra-osseous cherubic lesions in his mandible was treated with an administration of 200 IU systemic calcitonin every other day via his nasal passage for duration of more than two years. After 30 months of calcitonin therapy, the lesions in the mandible were significantly regressed, and calcitonin application was ceased. Despite some drawbacks, such as unpredictable efficient absorption and patient tolerability, nasal administration is the easiest way to use calcitonin therapy on children. In this report, every-other-day applications of calcitonin increased patient tolerability and might be considered as an effective treatment for mild cherubic lesions. (Eur J Dent 2011;5:486-491)
Title: Treatment of Cherubism with Salmon Calcitonin: A Case Report
Description:
ABSTRACTCherubism is a familial disease of the jaws which is inherited via autosomal dominant manner.
Typical features of cherubism include a painless bilateral, symmetrical enlargement of the jaws, misalignment of teeth, and intra-osseous central giant cell granuloma-like lesions, which are usually evident in early childhood.
Treatment of cherubism consists of local curettage of the lesions, jaw contouring, intralesional steroid injections, and systemic calcitonin administration as well.
Calcitonin therapy for central giant cell granuloma of the jaws is well documented, and favorable results have been achieved.
However, fewer reports have been presented in regard to calcitonin administration for cherubism.
In the present report, a 14-year-old boy with cherubism who had intra-osseous cherubic lesions in his mandible was treated with an administration of 200 IU systemic calcitonin every other day via his nasal passage for duration of more than two years.
After 30 months of calcitonin therapy, the lesions in the mandible were significantly regressed, and calcitonin application was ceased.
Despite some drawbacks, such as unpredictable efficient absorption and patient tolerability, nasal administration is the easiest way to use calcitonin therapy on children.
In this report, every-other-day applications of calcitonin increased patient tolerability and might be considered as an effective treatment for mild cherubic lesions.
(Eur J Dent 2011;5:486-491).
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
SH3BP2 Cherubism Mutation Potentiates TNF-α–Induced Osteoclastogenesis via NFATc1 and TNF-α–Mediated Inflammatory Bone Loss
SH3BP2 Cherubism Mutation Potentiates TNF-α–Induced Osteoclastogenesis via NFATc1 and TNF-α–Mediated Inflammatory Bone Loss
ABSTRACT
Cherubism (OMIM# 118400) is a genetic disorder with excessive jawbone resorption caused by mutations in SH3 domain bi...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Etanercept Administration to Neonatal SH3BP2 Knock-In Cherubism Mice Prevents TNF-α-Induced Inflammation and Bone Loss
Etanercept Administration to Neonatal SH3BP2 Knock-In Cherubism Mice Prevents TNF-α-Induced Inflammation and Bone Loss
ABSTRACT
Cherubism is a genetic disorder of the craniofacial skeleton caused by gain-of-function mutations in the signa...
Pacific Salmon: Ecology and Management of Western Alaska’s Populations
Pacific Salmon: Ecology and Management of Western Alaska’s Populations
<em>Abstract.</em>—In the late 1990s and early 2000s, large declines in numbers of chum salmon <em>Oncorhynchus keta </em>and Chinook salmon <em>O. ts...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer
Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer
Men and women differ in thyroidal C-cell mass and calcitonin secretion. This difference may have implications for the definition of calcitonin thresholds to distinguish sporadic C-...
Hatchery-Origin Stray Rates and Total Run Characteristics for Pink Salmon and Chum Salmon Returning to Prince William Sound, Alaska, in 2013–2015
Hatchery-Origin Stray Rates and Total Run Characteristics for Pink Salmon and Chum Salmon Returning to Prince William Sound, Alaska, in 2013–2015
Abstract
Pacific salmon hatcheries support important commercial fisheries for Pink Salmon Oncorhynchus gorbuscha and Chum Salmon O. keta in Prince William Sound (PWS...

